This week, we chat with Affibody CEO David Bejker, and Martin Gleave, founder and chief medical officer at Sustained Therapeutics.

Times:

03:47 Affibody

23:28 Sustained Therapeutics

Sustained Therapeutics

A spin-out from the University of British Columbia in Canada, Sustained Therapeutics utilises a proprietary polymer gel technology to develop locally injected, long-acting medications. The platform is designed to release active pharmaceutical ingredients in a controlled manner over several weeks, aiming to replace traditional oral delivery or frequent injections.

While the primary focus is on managing acute and chronic pain without the use of opioids, the ...